HGH-derived fat-targeting peptide fragment. Commonly searched as HGH Frag, Fragment 176-191, or HGH Fragment. Check label, concentration, and supplier before ordering.
Growth hormone releasing factor analogue peptide vial. Commonly searched as Tesamorelin 5 mg, GHRH analogue mid vial, or Tesamorelin multi-week protocol. Check label, concentration, and supplier before ordering.
Growth hormone releasing factor analogue peptide vial. Commonly searched as Tesamorelin 2 mg, GHRH analogue entry vial, or Tesamorelin starter protocol. Check label, concentration, and supplier before ordering.
Thymosin Beta 4 peptide vial for tissue repair research. Commonly searched as TB-500 2 mg, Thymosin Beta 4 entry vial, or TB500 muscle healing peptide. Check label, concentration, and supplier before ordering.
Ipamorelin entry-level GH secretagogue peptide vial for growth hormone release research. Commonly searched as Ipamorelin 2 mg, beginner GHRP, or Ipamorelin starter vial. Check label, concentration, and supplier before ordering.
Ipamorelin high-content GH secretagogue peptide vial for extended growth hormone release research. Commonly searched as Ipamorelin 10 mg, Ipamorelin large vial, or GHRP Ipamorelin 10mg. Check label, concentration, and supplier before ordering.
AOD 9604 entry-level fat loss peptide vial for weight management research. Commonly searched as AOD 9604 2 mg, AOD9604 starter vial, or HGH fragment 176-191. Check label, concentration, and supplier before ordering.
PEGylated splice variant of IGF-1 for muscle repair and satellite cell research. Introductory vial format. Commonly searched as PEG-MGF. Check vial, label, and supplier.
GH secretagogue peptide vial. Commonly searched as GHRP-2. Check vial, label, and supplier.
High-volume GH secretagogue peptide vial. Commonly searched as GHRP-2. Check vial, label, and supplier.
Most potent oral AI for aggressive estrogen suppression. Used on high-dose cycles, for estrogen-sensitive users, and for gynecomastia flares. Dose carefully - suppression at 2.5mg daily is near-complete.
Ghrelin receptor agonist that stimulates GH release from the pituitary. Stronger GH pulse and less hunger than GHRP-6. Best combined with a GHRH peptide (CJC-1295, Sermorelin) for synergistic GH release. Reconstitute with bacteriostatic water. Check vial, label, and supplier.
The most selective GHRP - triggers GH release from the pituitary with minimal cortisol, prolactin, and appetite stimulation. Standalone vial for pairing with any GHRH peptide (CJC no DAC, CJC DAC, Sermorelin) or for solo use. Reconstitute with bacteriostatic water. Check vial, label, and supplier.
The most potent GHRP by GH pulse amplitude - a hexapeptide ghrelin receptor agonist that produces the strongest GH release among commonly used GHRPs. Also studied for cardioprotective properties via CD36 receptor. Pairs with any GHRH (CJC no DAC, Sermorelin). Reconstitute with bacteriostatic water. Check vial, label, and supplier.
The only GHRH analog with FDA approval history (Egrifta, for visceral fat reduction). A 44-amino acid modified GHRH peptide targeting GH release with a primary research focus on abdominal fat. Used standalone or with a GHRP. Plan vial quantity carefully - clinical doses are 1-2 mg per day. Reconstitute with bacteriostatic water. Check vial, label, and supplier.
A neuropeptide that acts upstream of GnRH to stimulate the HPG axis - triggering LH, FSH, and downstream testosterone release via KISS1R receptor activation. Primary research contexts: HPG axis restoration, PCT, fertility, and testosterone support without exogenous suppression. Reconstitute with bacteriostatic water. Check vial, label, and supplier.
Synthetic analog of alpha-melanocyte-stimulating hormone (alpha-MSH). Non-selective melanocortin receptor agonist with potent MC1R activity driving eumelanin production and skin darkening. Also activates MC4R via CNS arousal pathways. SubQ injection. Loading and maintenance protocol.
Synthetic analog of alpha-melanocyte-stimulating hormone (alpha-MSH). Non-selective melanocortin receptor agonist with potent MC1R activity driving eumelanin production and skin darkening. Also activates MC4R via CNS arousal pathways. SubQ injection. 5 mg vial format for shorter protocols or maintenance phase use.
5-alpha reductase inhibitor for androgenic alopecia and DHT control on cycle. At 5mg per tablet - this is the Proscar/BPH strength, not the 1mg Propecia dose used for hair loss. Tablet splitting required. Only effective against testosterone-derived DHT - does not protect against hair loss from Trenbolone or DHT-derivative steroids. Check label, concentration, and supplier.
Adipotide (FTPP) is a research peptide targeting prohibitin on adipose vasculature. Also searched as Adipotide FTPP, fat-targeted proapoptotic peptide. Check vial, label, and supplier before ordering.
Long-acting GHRH analogue. Commonly searched as CJC-1295 with DAC, CJC DAC, and modified GRF long-acting. Check vial, label, and supplier.
Reproductive peptide researched for GnRH, LH and FSH signaling. Commonly searched as KP-10. Check vial, label, and supplier.
Melanocortin peptide researched for tanning and arousal context. Commonly searched as MT-2. Check vial, label, and supplier.
GHRH analog research peptide in a lyophilised 5 mg vial. Commonly researched for GH release and GH secretagogue context. Check vial, label, and supplier.
Metabolic research compound in a lyophilised 10 mg vial. Commonly researched for NNMT inhibition, cellular energy, and metabolic context. Check vial, label, and supplier.
Immune peptide in a lyophilised 2 mg vial. Commonly researched for immune modulation, T-cell activity, and immune support context. Check vial, label, and supplier.
Long-acting GHRH analog in a lyophilised 2 mg vial. Commonly researched for GH release and secretagogue protocols. Check vial, label, and supplier.
GHRP hexapeptide in a lyophilised 2 mg vial. Commonly researched for GH release and secretagogue protocols. Check vial, label, and supplier.
GHRH analog in a lyophilised 2 mg vial. Commonly researched for GH release and GHRP/GHRH stack protocols. Check vial, label, and supplier.
Nootropic ACTH analogue research peptide in a lyophilised 2 mg vial. Commonly researched for focus, learning, and memory context. Check vial, label, and supplier.
GHRH analog research peptide in a lyophilised 10 mg vial. Commonly researched for GH release and GH secretagogue context. Check vial, label, and supplier.
GHRH analog research peptide in a lyophilised 2 mg vial. Commonly researched for GH release and GH secretagogue context. Check vial, label, and supplier.
Sleep-related peptide in a lyophilised 2 mg vial. Commonly researched for deep sleep, sleep quality, and recovery context. Check vial, label, and supplier.
GLP-1 receptor agonist peptide. Commonly searched as Semaglutide, Ozempic peptide, or GLP-1 5 mg. Check label, concentration, and supplier before ordering.
GLP-1 receptor agonist peptide. Commonly searched as Semaglutide 10 mg, GLP-1 large vial, or Semaglutide extended protocol. Check label, concentration, and supplier before ordering.
Dual GIP/GLP-1 receptor agonist peptide. Commonly searched as Tirzepatide 2 mg, Mounjaro starter vial, or dual incretin entry dose. Check label, concentration, and supplier before ordering.
FDA-referenced GHRH analog, 5mg lyophilized per vial. Searched as Tesamorelin, Tesamorelin peptide, Egrifta. Check vial, seal, and supplier before use.